The findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial
Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies
PASSAMONTI, FRANCESCO;
2009-01-01
Abstract
The findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
